Literature DB >> 36266726

CASA: a comprehensive database resource for the COVID-19 Alternative Splicing Atlas.

Yaxin Chen1, Gang Wang1, Jingyi Li2, Lei Xia3, Lin Zhu1, Wenxing Li4, Qiang Luo2, Yinlu Liao2, Yao Lin2, Liyun Bi1, Hubin Chen2, Jiemei Chu2, Yueqi Li2, Jinming Su2, Li Ye2, Jun-Jun Jiang2, Hao Liang5, Weimin Li6, Sanqi An7.   

Abstract

BACKGROUND: As a key process in transcriptional regulatory mechanisms, alternative splicing (AS) plays a crucial role in maintaining the diversity of RNA and protein expression, and mediates the immune response in infectious diseases, especially for the COVID-19. Therefore, urgent data gathering and more research of AS profiles in microbe-infected human cells are needed to improve understanding of COVID-19 and related infectious diseases. Herein, we have created CASA, the COVID-19 Alternative Splicing Atlas to provide a convenient computing platform for studies of AS in COVID-19 and COVID-19-related infectious diseases.
METHODS: In CASA, we reanalyzed thousands of RNA-seq datasets generated from 65 different tissues, organoids and cell lines to systematically obtain quantitative data on AS events under different conditions. A total of 262,994 AS events from various infectious diseases with differing severity were detected and visualized in this database. In order to explore the potential function of dynamics AS events, we performed analysis of functional annotations and drug-target interactions affected by AS in each dataset. RNA-binding proteins (RBPs), which may regulate these dynamic AS events are also provided for users in this database.
RESULTS: CASA displays microbe-induced alterations of the host cell splicing landscape across different virus families and helps users identify condition-specific splicing patterns, as well as their potential regulators. CASA may greatly facilitate the exploration of AS profiles and novel mechanisms of host cell splicing by viral manipulation. CASA is freely available at http://www.splicedb.net/casa/ .
© 2022. The Author(s).

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 36266726      PMCID: PMC9583055          DOI: 10.1186/s12967-022-03699-8

Source DB:  PubMed          Journal:  J Transl Med        ISSN: 1479-5876            Impact factor:   8.440


  32 in total

Review 1.  Advances in Analyzing Virus-Induced Alterations of Host Cell Splicing.

Authors:  Usama Ashraf; Clara Benoit-Pilven; Vincent Lacroix; Vincent Navratil; Nadia Naffakh
Journal:  Trends Microbiol       Date:  2018-12-19       Impact factor: 17.079

2.  rMATS: robust and flexible detection of differential alternative splicing from replicate RNA-Seq data.

Authors:  Shihao Shen; Juw Won Park; Zhi-xiang Lu; Lan Lin; Michael D Henry; Ying Nian Wu; Qing Zhou; Yi Xing
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-05       Impact factor: 11.205

3.  rMATS-DVR: rMATS discovery of differential variants in RNA.

Authors:  Jinkai Wang; Yang Pan; Shihao Shen; Lan Lin; Yi Xing
Journal:  Bioinformatics       Date:  2017-07-15       Impact factor: 6.937

4.  OAS1 gene, Spike protein variants and persistent COVID-19-related anosmia: may the olfactory disfunction be a harbinger of future neurodegenerative disease?

Authors:  A Di Stadio; E Bernitsas; M Ralli; C Severini; M J Brenner; C Angelini
Journal:  Eur Rev Med Pharmacol Sci       Date:  2022-01       Impact factor: 3.507

5.  rMAPS: RNA map analysis and plotting server for alternative exon regulation.

Authors:  Juw Won Park; Sungbo Jung; Eric C Rouchka; Yu-Ting Tseng; Yi Xing
Journal:  Nucleic Acids Res       Date:  2016-05-12       Impact factor: 16.971

6.  Betacoronavirus-specific alternate splicing.

Authors:  Guy Karlebach; Bruce Aronow; Stephen B Baylin; Daniel Butler; Jonathan Foox; Shawn Levy; Cem Meydan; Christopher Mozsary; Amanda M Saravia-Butler; Deanne M Taylor; Eve Wurtele; Christopher E Mason; Afshin Beheshti; Peter N Robinson
Journal:  Genomics       Date:  2022-01-22       Impact factor: 5.736

7.  A genetic link between risk for Alzheimer's disease and severe COVID-19 outcomes via the OAS1 gene.

Authors:  Naciye Magusali; Andrew C Graham; Thomas M Piers; Pantila Panichnantakul; Umran Yaman; Maryam Shoai; Regina H Reynolds; Juan A Botia; Keeley J Brookes; Tamar Guetta-Baranes; Eftychia Bellou; Sevinc Bayram; Dimitra Sokolova; Mina Ryten; Carlo Sala Frigerio; Valentina Escott-Price; Kevin Morgan; Jennifer M Pocock; John Hardy; Dervis A Salih
Journal:  Brain       Date:  2021-12-31       Impact factor: 15.255

8.  Abnormal global alternative RNA splicing in COVID-19 patients.

Authors:  Changli Wang; Lijun Chen; Yaobin Chen; Wenwen Jia; Xunhui Cai; Yufeng Liu; Fenghu Ji; Peng Xiong; Anyi Liang; Ren Liu; Yuanlin Guan; Zhongyi Cheng; Yejing Weng; Weixin Wang; Yaqi Duan; Dong Kuang; Sanpeng Xu; Hanghang Cai; Qin Xia; Dehua Yang; Ming-Wei Wang; Xiangping Yang; Jianjun Zhang; Chao Cheng; Liang Liu; Zhongmin Liu; Ren Liang; Guopin Wang; Zhendong Li; Han Xia; Tian Xia
Journal:  PLoS Genet       Date:  2022-04-14       Impact factor: 6.020

9.  TCGASpliceSeq a compendium of alternative mRNA splicing in cancer.

Authors:  Michael Ryan; Wing Chung Wong; Robert Brown; Rehan Akbani; Xiaoping Su; Bradley Broom; James Melott; John Weinstein
Journal:  Nucleic Acids Res       Date:  2015-11-23       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.